trial
as of 2026-07-01Role of Minocycline in First Episode Psychosis
NCTId NCT00916461
at a glance
Phase 1, Phase 2 · Completed
Enrollment 52 (actual)
Sponsored by Stanley Medical Research Institute
Primary completion 2008-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1, Phase 2
Status
Completed
Enrollment
52 (actual)
Study type
Interventional
Allocation
Randomized
Model
—
Masking
Double
Start
2006-05
Primary completion
2008-03
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Drugs
Sponsors
Stanley Medical Research InstituteLead Sponsor
Pakistan Institute of Living and LearningCollaborator
University of Sao PauloCollaborator
Investigators
3
Prof Imran B Chaudhry, MDPrincipal Investigator
Jaime EC Hallak, MDStudy Director
Nusrat Husain, MDStudy Director
Sites
4 total
São Paulo, BrazilKarachi, PakistanKarachi, PakistanRawalpindi, Pakistan
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
52
Phase
PHASE1,PHASE2
Primary Completion Date
2008-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator